Literature DB >> 19035167

[The clinical significance of autoantibodies against acetylcholine muscarinic 3 receptor in primary Sjögren's syndrome].

Ying Wu1, Meng-Tao Li, Yan Zhao, Sheng Feng, Li Su, Yi Dong.   

Abstract

OBJECTIVE: To detect anti-M3 receptor antibodies in primary Sjögren's syndrome (pSS) patients and to explore its association with clinical manifestations.
METHODS: Anti-M3 antibodies were tested in 70 patients with pSS , 50 patients with systemic lupus erythematosus (SLE) and 76 normal controls with ELISA and Western blot. The correlation between anti-M3 antibodies and other clinical manifestations was analyzed.
RESULTS: (1) The positive rate of anti-M3 antibodies in pSS was 47.14% using ELISA and 60.00% using Western blot in SLE 4.00% using ELISA and 12.00% using Western blot and in normal controls 14.47% using ELISA and 15.79% using Western blot. (2) The incidence of schirmer test, tear break-up time (BUT), whole saliva flow rate, punctate epithelial erosions (PEE) on the corneas and external eye examination were not significantly different between the anti-M3 positive and negative groups. (3) The incidences of IgG, rheumatoid factor, SSB and fluorescence index (FI) > 3 were higher in the positive group than in the negative group using ELISA.
CONCLUSION: The positive rate of anti-M3 antibodies is higher in pSS than in SLE and normal controls and in some degree it has correlation with the lesion in salivary gland.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19035167

Source DB:  PubMed          Journal:  Zhonghua Nei Ke Za Zhi        ISSN: 0578-1426


  2 in total

1.  Immunoglobulin G from breast cancer patients in stage I stimulates muscarinic acetylcholine receptors in MCF7 cells and induces proliferation. Participation of nitric oxide synthase-derived nitric oxide.

Authors:  María Pía Negroni; Gabriel L Fiszman; María E Azar; Carlos Cresta Morgado; Alejandro J Español; Laura T Pelegrina; Eulalia de la Torre; María Elena Sales
Journal:  J Clin Immunol       Date:  2010-02-16       Impact factor: 8.317

2.  Meta-analysis of anti-muscarinic receptor type 3 antibodies for the diagnosis of Sjögren syndrome.

Authors:  Chuiwen Deng; Chaojun Hu; Si Chen; Jing Li; Xiaoting Wen; Ziyan Wu; Yuan Li; Fengchun Zhang; Yongzhe Li
Journal:  PLoS One       Date:  2015-01-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.